European equities traded in the US as American depositary receipts were higher late Tuesday morning, rising 0.50% to 1,356.26 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biotech firm Evaxion Biotech (EVAX), which soared 36.3%, followed by biopharmaceutical company DBV Technologies (DBVT), which rose 10%. They were followed by financial services companies Banco Bilbao Vizcaya Argentaria (BBVA) and Banco Santander (SAN), which were up 3.3% and 3.6%, respectively.
The decliners from continental Europe were led by medical device maker EDAP TMS (EDAP), which fell 1.2%, followed by consumer goods company Unilever (UL) and pharmaceutical company Novo Nordisk (NVO), which were down 0.4% and 0.1% respectively.
From the UK and Ireland, the gainers were led by Akari Therapeutics (AKTX) and biopharmaceutical companies TC Biopharm (TCBP), which rose 5.9% and 3.3% respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group (MREO) and Verona Pharma (VRNA), which increased 2% and 1% respectively.
The decliners from the UK and Ireland were led by telecommunications operator Vodafone (VOD) and biopharmaceutical company NuCana (NCNA), which dropped 5% and 3.4% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which lost 0.2%.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。